BSX Stock Recent News
BSX LATEST HEADLINES
In the most recent trading session, Boston Scientific (BSX) closed at $84.54, indicating a +0.86% shift from the previous trading day.
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive MedSurg market share gain.
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
MARLBOROUGH, Mass. , Sept. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System.
Boston Scientific (BSX) closed at $83.08 in the latest trading session, marking a -0.5% move from the prior day.
S&P 500 stocks such as NVIDIA, Boston Scientific and American Water Works are, currently, exhibiting superb earnings growth.
Ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, BAX, HAE and PAHC are well-poised to gain from the favorable factors.
Boston Scientific (BSX) possesses solid growth attributes, which could help it handily outperform the market.
Does Boston Scientific (BSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.